BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer control

BACKGROUND: Cancer immunotherapies can produce complete therapeutic responses, however, outcomes in ovarian cancer (OC) are modest. While adoptive T-cell transfer (ACT) has been evaluated in OC, durable effects are rare. Poor therapeutic efficacy is likely multifactorial, stemming from limited antig...

Descripción completa

Detalles Bibliográficos
Autores principales: McGray, A J Robert, Chiello, Jessie L, Tsuji, Takemasa, Long, Mark, Maraszek, Kathryn, Gaulin, Nicole, Rosario, Spencer R, Hess, Suzanne M, Abrams, Scott I, Kozbor, Danuta, Odunsi, Kunle, Zsiros, Emese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314690/
https://www.ncbi.nlm.nih.gov/pubmed/37647218
http://dx.doi.org/10.1136/jitc-2023-006863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314690/
https://www.ncbi.nlm.nih.gov/pubmed/37647218
http://dx.doi.org/10.1136/jitc-2023-006863

Ejemplares similares